Skip to content

GRAIL, Inc. GRAL Free cash flow yield

Free cash flow yield at other companies

Abbott logo
AbbottABT
4.1%+1.2pp
Guardant Health logo
Guardant HealthGH
-2%-0.8pp
Natera, Inc. logo
Natera, Inc.NTRA
0.4%-0.1pp
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
-6%
Immunome logo
ImmunomeIMNM
-8.3%-3.4pp
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
-1.4%-0.7pp

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.62B+145%
Enterprise value$2.6B+164%
P/S16.8×+8.6×

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Where this comes from

Calculated from GRAIL, Inc.’s reported figures.

Based on trailing twelve months.

The official record: GRAIL, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about GRAIL, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GRAIL, Inc.'s free cash flow yield?
GRAIL, Inc. (GRAL) reported free cash flow yield of -13.8% in Q1 2026.
How has GRAIL, Inc.'s free cash flow yield changed year-over-year?
GRAIL, Inc.'s free cash flow yield increased by 74.5% year-over-year, from -54% to -13.8%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.